Cargando…
Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer
SIMPLE SUMMARY: Surgery has shown that early-stage esophageal cancer is accompanied by extensive lymph node metastasis. Therefore, elective nodal irradiation is indispensable for chemoradiotherapy instead of surgery for the radical cure of esophageal cancer. In contrast, attention must be paid to ad...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913169/ https://www.ncbi.nlm.nih.gov/pubmed/36765818 http://dx.doi.org/10.3390/cancers15030860 |
_version_ | 1784885359853699072 |
---|---|
author | Tamamura, Hiroyasu Hasatani, Kenkei Matsumoto, Sae Asahi, Satoko Tatebe, Hitoshi Sato, Yoshitaka Matsusita, Keiichiro Tameshige, Yuji Maeda, Yoshikazu Sasaki, Makoto Takamatsu, Shigeyuki Yamamoto, Kazutaka |
author_facet | Tamamura, Hiroyasu Hasatani, Kenkei Matsumoto, Sae Asahi, Satoko Tatebe, Hitoshi Sato, Yoshitaka Matsusita, Keiichiro Tameshige, Yuji Maeda, Yoshikazu Sasaki, Makoto Takamatsu, Shigeyuki Yamamoto, Kazutaka |
author_sort | Tamamura, Hiroyasu |
collection | PubMed |
description | SIMPLE SUMMARY: Surgery has shown that early-stage esophageal cancer is accompanied by extensive lymph node metastasis. Therefore, elective nodal irradiation is indispensable for chemoradiotherapy instead of surgery for the radical cure of esophageal cancer. In contrast, attention must be paid to adverse effects when applying radiation to a wide area. Adverse events are generally more intense with high-dose irradiation. Therefore, determining the appropriate dose for prophylactic irradiation to the elective nodal area is important. However, the appropriate dose has not been fixed. In this study, the therapeutic effects and adverse events of a group of 36 Gy elective nodal irradiation doses were similar to those of 40 Gy or higher. This study’s results indicate that preventing lymph node metastasis at lower doses is possible, thus suppressing adverse events. ABSTRACT: We evaluated elective nodal irradiation (ENI) doses during radical chemoradiotherapy (CRT) for esophageal cancer (EC). A total of 79 patients (65 men and 14 women) aged 52–80 years with T1-3, N0-3, and M0 (including M1ly) who underwent CRT for EC during November 2012–September 2019 were eligible for this retrospective analysis. Patients were divided into two groups: the high-dose group (HG), including 38 patients who received ≥40 Gy as ENI; and the low-dose group (LG), including 41 patients who received <40 Gy. The median doses were 40.0 and 36.0 Gy in HG and LG, respectively. During the follow-up (median: 36.7 months), no lymph node recurrence was observed in the ENI field in all patients. Lymph node recurrence near the ENI field was observed in six patients. No significant differences were observed between the two groups in median overall survival, progression-free survival, and local control. Grade 3–4 acute and late adverse events were observed in five patients of HG and six patients of LG, respectively. No ulceration or stricture was observed in the ENI field on endoscopy examined with 58 Gy irradiation. In conclusion, an ENI dose of 36 Gy could be considered to control the elective nodes of EC. |
format | Online Article Text |
id | pubmed-9913169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99131692023-02-11 Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer Tamamura, Hiroyasu Hasatani, Kenkei Matsumoto, Sae Asahi, Satoko Tatebe, Hitoshi Sato, Yoshitaka Matsusita, Keiichiro Tameshige, Yuji Maeda, Yoshikazu Sasaki, Makoto Takamatsu, Shigeyuki Yamamoto, Kazutaka Cancers (Basel) Article SIMPLE SUMMARY: Surgery has shown that early-stage esophageal cancer is accompanied by extensive lymph node metastasis. Therefore, elective nodal irradiation is indispensable for chemoradiotherapy instead of surgery for the radical cure of esophageal cancer. In contrast, attention must be paid to adverse effects when applying radiation to a wide area. Adverse events are generally more intense with high-dose irradiation. Therefore, determining the appropriate dose for prophylactic irradiation to the elective nodal area is important. However, the appropriate dose has not been fixed. In this study, the therapeutic effects and adverse events of a group of 36 Gy elective nodal irradiation doses were similar to those of 40 Gy or higher. This study’s results indicate that preventing lymph node metastasis at lower doses is possible, thus suppressing adverse events. ABSTRACT: We evaluated elective nodal irradiation (ENI) doses during radical chemoradiotherapy (CRT) for esophageal cancer (EC). A total of 79 patients (65 men and 14 women) aged 52–80 years with T1-3, N0-3, and M0 (including M1ly) who underwent CRT for EC during November 2012–September 2019 were eligible for this retrospective analysis. Patients were divided into two groups: the high-dose group (HG), including 38 patients who received ≥40 Gy as ENI; and the low-dose group (LG), including 41 patients who received <40 Gy. The median doses were 40.0 and 36.0 Gy in HG and LG, respectively. During the follow-up (median: 36.7 months), no lymph node recurrence was observed in the ENI field in all patients. Lymph node recurrence near the ENI field was observed in six patients. No significant differences were observed between the two groups in median overall survival, progression-free survival, and local control. Grade 3–4 acute and late adverse events were observed in five patients of HG and six patients of LG, respectively. No ulceration or stricture was observed in the ENI field on endoscopy examined with 58 Gy irradiation. In conclusion, an ENI dose of 36 Gy could be considered to control the elective nodes of EC. MDPI 2023-01-30 /pmc/articles/PMC9913169/ /pubmed/36765818 http://dx.doi.org/10.3390/cancers15030860 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tamamura, Hiroyasu Hasatani, Kenkei Matsumoto, Sae Asahi, Satoko Tatebe, Hitoshi Sato, Yoshitaka Matsusita, Keiichiro Tameshige, Yuji Maeda, Yoshikazu Sasaki, Makoto Takamatsu, Shigeyuki Yamamoto, Kazutaka Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer |
title | Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer |
title_full | Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer |
title_fullStr | Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer |
title_full_unstemmed | Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer |
title_short | Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer |
title_sort | evaluation of exposure doses of elective nodal irradiation in chemoradiotherapy for advanced esophageal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913169/ https://www.ncbi.nlm.nih.gov/pubmed/36765818 http://dx.doi.org/10.3390/cancers15030860 |
work_keys_str_mv | AT tamamurahiroyasu evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT hasatanikenkei evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT matsumotosae evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT asahisatoko evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT tatebehitoshi evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT satoyoshitaka evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT matsusitakeiichiro evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT tameshigeyuji evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT maedayoshikazu evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT sasakimakoto evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT takamatsushigeyuki evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer AT yamamotokazutaka evaluationofexposuredosesofelectivenodalirradiationinchemoradiotherapyforadvancedesophagealcancer |